GP-Act III Acquisition Corp. 8-K
Research Summary
AI-generated summary
GP-Act III Acquisition Corp. Approves Extension to Nov 13, 2026
What Happened
GP-Act III Acquisition Corp. (GPAT) announced that at an extraordinary general meeting reconvened on May 12, 2026 shareholders approved an Extension Amendment to push the deadline to complete a business combination from May 13, 2026 to November 13, 2026. The Company and Continental Stock Transfer & Trust Company executed Amendment No. 1 to the Investment Management Trust Agreement (the Trust Amendment) to extend the trustee’s liquidation date to November 13, 2026. The filing also describes Non-Redemption Agreements between the sponsor (GP-Act III Sponsor LLC) and certain investors under which those investors agreed not to redeem and to vote for the amendments; the sponsor agreed to transfer a total of 403,720 Class A shares to those investors upon closing of a business combination, subject to conditions.
Key Details
- Shareholder vote (May 12, 2026): 23,799,592 votes FOR and 7,065,138 votes AGAINST for both the Extension Amendment and Trust Amendment. 30,864,730 shares (≈85.88% of outstanding) were represented.
- Extension: deadline to complete a business combination and related liquidation/redeem actions extended from May 13, 2026 to November 13, 2026.
- Redemptions: Holders of 19,776,272 Class A shares elected to redeem for cash at ≈$10.89/share, totaling ≈$215,421,832; approximately $97,750,320 remains in the trust account.
- Non-Redemption Agreements cover an aggregate of 8,074,387 Class A shares; Sponsor HoldCo agreed to transfer 403,720 Class A shares to participating investors upon closing, conditional on those investors not redeeming and voting for the amendments.
Why It Matters
The approved extension gives GP-Act III roughly six more months to identify and close a business combination, delaying mandatory wind-up/liquidation actions. However, substantial redemptions reduced the trust balance to about $97.8 million, which affects the cash available per share for potential deal-related redemptions and can influence deal structure or financing needs. The Non-Redemption Agreements and sponsor share transfers indicate sponsor efforts to secure votes and limit further redemptions, which could affect shareholder composition and dilution at closing.
Loading document...